Polypeptides for promoting cell attachment
AssigneeThe Scripps Research Institute
InventorsMark H. Ginsberg, Edward F. Plow, Ronald Bowditch
Life of this patent
Estimating the term…
Abstract
Novel polypeptides derived from human fibronectin are described which bind to integrin receptors expressed by cells. The receptor binding site of human fibronectin begins at amino acid residue 1394 and ends at residue 1400 of fibronectin. The polypeptides facilitate attachment of cells to substrates either alone or in conjunction with RGD-containing peptides. Vectors, fusion proteins and antibodies are also described. Methods for promoting cell attachment and for inhibiting cell adhesion are also described.
Claims6
A vector including a nucleic acid sequence that encodes a polypeptide having a length of no more than about 100 amino acid residues that includes an amino acid residue sequence represented by the formula:
- AspArgXaa.sub.1 ProHisHaa.sub.2 Arg (SEQ ID NO 1). wherein Xaa.sub.1 and Xaa.sub.2 are any amino acid residue and said polypeptide binds GPIIb-IIIa in an ArgGlyAsp-indepependent manner.
A vector including a nucleic acid sequence that encodes a polypeptide having a length of no more than about 100 amino acid residues that includes an amino acid residue sequence AspArgXaa.sub.1 ProHisXaa.sub.2 Arg (SEQ ID NO 1), wherein Xaa.sub.1 and Xaa.sub.2 are any amino acid residue and said polypeptide binds GPIIb-IIa in an ArgGlyAsp-independent manner.
A vector including a nucleic acid sequence that encodes a polypeptide having a length of no more than about 100 amino acid residues that includes an amino acid residue sequence -AspArgXaa.sub.1 ProHisXaa.sub.2 ArgXaa.sub.3 Xaa.sub.4 Xaa.sub.5 Xaa.sub.6 - (SEQ ID NO 2), wherein Xaa.sub.1 is Val or Ala, Xaa.sub.2 is Ser or Ala, Xaa.sub.3 is Asn or Ala, Xaa.sub.4 is Ser or Ala, Xaa.sub.5 is Ile or Ala, and Xaa.sub.6 is Thr or Ala.
A vector including a nucleic acid sequence that encodes a polypeptide that inhibits fibronectin binding to GPIIb-IIIa said polypeptide having a length of no more than about 100 amino acid residues that includes an amino acid residue sequence selected from the group consisting of the sequences shown in SEQ ID NO:2 from residues 248-274, 197-274, 217-274 and 73-274.
Dependencies are inferred from the claim text.